Clinical stage immuno-oncology company Imugene Limited (ASX:IMU) has been granted a trading halt by the ASX, with its shares placed in pre-open.
Imugene is currently preparing to release capital raising details.
The company is developing HER-2+ gastric and breast cancer immunotherapies.
The halt will remain in place until the opening of trade on Wednesday 9th September 2015, or earlier if an announcement is made to the market.
- Forums
- ASX - By Stock
- News: Imugene Limited on road to raising
Clinical stage immuno-oncology company Imugene Limited (ASX:IMU)...
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $768.4M |
Open | High | Low | Value | Volume |
10.5¢ | 10.8¢ | 10.0¢ | $746.7K | 7.120M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
176 | 10004604 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 420568 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
176 | 10004604 | 0.100 |
12 | 525784 | 0.099 |
10 | 716843 | 0.098 |
11 | 640958 | 0.097 |
10 | 772491 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 420568 | 8 |
0.110 | 7967553 | 66 |
0.115 | 6445983 | 53 |
0.120 | 11666760 | 87 |
0.125 | 13968032 | 53 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
10.3¢ |
  |
Change
0.000 ( 2.40 %) |
|||
Open | High | Low | Volume | ||
10.3¢ | 10.5¢ | 10.3¢ | 1930285 | ||
Last updated 15.59pm 28/03/2024 ? |
Featured News
IMU (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online